corona pandemic
Adapted Biontech vaccine also for children from 5 years
The adapted vaccine should be just as well tolerated and safe as the original preparation. photo
© Kay Nietfeld/dpa
The adapted vaccine for the corona subvariants BA.4 and BA.5 has already been approved as a booster for people aged 12 and over. Now the European Medicines Agency recommends the vaccine for the very young.
The European Medicines Agency (EMA) has recommended the approval of the Corona vaccine from Biontech/Pfizer, which has been adapted to the omicron variant, for children over the age of five. This was announced by the EMA in Amsterdam.
The vaccine, adapted for the subvariants BA.4 and BA.5, had already been approved as a booster for people aged 12 and over. The EU Commission still has to approve the recommendation, but that is considered a formality.
The experts expect broader protection against different corona variants. The manufacturers pointed to studies that showed strong immune responses against subvariants BA.4 and BA.5 in people over 18 years of age 30 days after vaccination. The adapted vaccine is just as well tolerated and safe as the original preparation.